AllSquare Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
AllSquare Wealth Management's GILD Position: Q1 2021 in Review
AllSquare Wealth Management sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 50 shares — an estimated $3K sold.
AllSquare Wealth Management first reported a position in GILD in Q4 2014 and held it in 24 quarters. The position peaked at $99K in Q4 2016. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.
- AllSquare Wealth Management reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
- AllSquare Wealth Management sold 50 Gilead Sciences shares in Q1 2021, an estimated $3K.
- AllSquare Wealth Management first reported a position in Gilead Sciences in Q4 2014 and held it in 24 quarters.
- AllSquare Wealth Management's Gilead Sciences position peaked at $99K in Q4 2016.
- 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.
Based on AllSquare Wealth Management's 13F filing for Q1 2021, filed 11 May 2021.